martes, 4 de abril de 2017

Lipoprotein biomarkers and risk of cardiovascular disease: a Laboratory Medicine Best Practices (LMBP) systematic review. | National Guideline Clearinghouse

Lipoprotein biomarkers and risk of cardiovascular disease: a Laboratory Medicine Best Practices (LMBP) systematic review. | National Guideline Clearinghouse

ngc

Laboratory Medicine Best Practices



  • GUIDELINE SUMMARY
    •  
  • NGC:011087
    •  
  • 2016 SEP

Lipoprotein biomarkers and risk of cardiovascular disease: a Laboratory Medicine Best Practices (LMBP) systematic review.

Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)